85 Minutes to Better Lives: Maxime Dely on the Power of Time in Photopheresis
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, posted on LinkedIn:
”85 minutes, no more, for an extracorporeal photopheresis procedure
Last week, during my final week at work, I accompanied a patient throughout her extracorporeal photopheresis session.
We talked, we shared a few stories… and suddenly, the end-of-procedure beep sounded.
Stopwatch in band: 85 minutes. No more
From the start of the procedure to disconnection. Ten minutes later, she was leaving in the ambulance.
Shorter than a football match or an old movie on TV.
For some, this time saving may seem small.
But for the patients’quality of life – and after hearing it directly from them – this gain is a big YES.
Extracorporeal photopheresis (ECP) is a technique used to treat certain immune diseases. It’s a demanding treatment – both medically and emotionally.
So why is this notion of time so important?
Because here, time saved is time given back.
In the centers where I’ve had the privilege to work and support the teams, online ECP has made it possible to save up to two hours compared with other so-called offline techniques.
It’s not just a technical achievement – it’s a real improvement in patient comfort.
An hour and a half less in the hospital means an hour and a half more at home, in one’s own environment, with one’s habits, comfort, and above all, close to loved ones.
And beyond the human benefit, this efficiency has a tangible impact:
- Better bed turnover,
- More available teams,
- And sometimes, one more treatment slot for another patient.
85 minutes, no more.
In photopheresis, as in many other areas of care, time itself is a form of healing.”

Keep up with Hemostasis Today.
-
Jan 29, 2026, 14:02Emma Lefrancais on Alarmin IL33 and Platelet Biology
-
Jan 29, 2026, 13:44Sia A: One of My Favorite Conversations from ASH
-
Jan 29, 2026, 13:34Sarah Matuja on Tanzania Stroke Project
-
Jan 29, 2026, 13:28Nancy Di Salvo on Amplifying Rare Disease Voices Through Partnership
-
Jan 29, 2026, 13:21Raul Santos Shares The Results of ORION-16: On The Efficacy and Safety of Inclisiran
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS
